Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| 2-(3,6,9,15-Tetrazabicyclo[9.3.1]pentadeca-1(15),11,13-trien-6-yl)ethanamine;hydrobromide | IC50 | 381100.0 [1] | |
| N-(Pyridin-2-ylmethyl)-2-(3,6,9,15-tetrazabicyclo[9.3.1]pentadeca-1(15),11,13-trien-6-yl)ethanamine;hydrochloride | IC50 | 178500.0 [1] | |
| N-(Pyridin-3-ylmethyl)-2-(3,6,9,15-tetrazabicyclo[9.3.1]pentadeca-1(15),11,13-trien-6-yl)ethanamine;hydrochloride | IC50 | 641000.0 [1] | |
| 1-N,4-N-Bis[2-(1H-imidazol-5-yl)ethyl]benzo[g]phthalazine-1,4-diamine | IC50 | 365800.0 [1] | |
| 1,4-Bis[3-(imidazol-1-yl)propylamino]benzo[g]phthalazine | IC50 | 67900.0 [1] | |
MLA | "Quest Database™ Superoxide dismutase Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 13 Dec. 2025, https://www.aatbio.com/data-sets/superoxide-dismutase-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 13). Quest Database™ Superoxide dismutase Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/superoxide-dismutase-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |